Acute myeloid leukemia (AML) is a blood cancer that has been historically challenging to treat. It often requires a bone marrow or stem cell transplant that can be curative but brings significant risks and side effects. However, new drugs and clinical trials have expanded treatment options and moderated side effects for many patients.

CAR T cell therapy is a new type of therapy for patients with multiple myeloma. It is currently available for patients who have relapsed after four or more rounds prior therapy. This presentation describes CAR T cell and related therapies as well as new drugs in the pipeline to treat patients with multiple myeloma

Anxiety and depression are common among cancer patients and survivors. Acceptance and commitment therapy is an effective tool for these problems. This presentation discusses the mental health challenges of transplant and GVHD patients and how this therapy can help them.

Sickle cell disease disproportionately affects African Americans. However, stem cell transplants and gene therapy offer promising treatment options. This presentation describes these treatments, their outcomes, and which treatments are appropriate for which patients.

Occupational therapists can help transplant recipients manage their fatigue, and redesign their lifestyle to improve quality of life, while recovering transplant and side effects such as graft-versus-host disease (GVHD).

Download Speaker Slides COVID 19 Winter Update: What Transplant Recipients Need to Know November 10, 2020 Presenters: Alyssa Letourneau MD, MPH, Medical Director, Antimicrobial Stewardship Program, Massachusetts General Hospital Areej

Caregivers for patients with graft-versus-host disease (GVHD) face unique challenges. It is important to understand how caring for a GVHD patient affects the caregiver’s physical and emotional health. This presentation discusses ways to cope and build resilience for the GVHD journey.

The COVID-19 virus poses a significant health risk for certain transplant recipients. As treatment options are limited and there is currently no vaccine, protecting yourself against getting the virus is the best stratgey to reduce the risk of developing a severe or fatal case of the disease.

Chronic ocular graft-versus-host disease (GVHD) affects more than 50% of patients who have chronic GVHD. A variety of therapies are available and should be approached in a step-ladder manner.

In this video you will learn, How do you know if you have a chance at natural conception after transplant? (For females and males) Reproductive Technology options Prior to transplant